{"id":682,"date":"2000-11-01T12:05:00","date_gmt":"2000-11-01T11:05:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2000\/klinisch-wichtige-pharmakologische-interaktionen-antimikrobieller-substanzen"},"modified":"2022-03-17T14:09:40","modified_gmt":"2022-03-17T13:09:40","slug":"klinisch-wichtige-pharmakologische-interaktionen-antimikrobieller-substanzen","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2000\/klinisch-wichtige-pharmakologische-interaktionen-antimikrobieller-substanzen","title":{"rendered":"Klinisch wichtige pharmakologische Interaktionen antimikrobieller Substanzen"},"content":{"rendered":"<p>Wir haben uns in diesem Jahr zweimal ausf\u00fchrlich mit bedeutsamen Arzneimittelinteraktionen besch\u00e4ftigt: zun\u00e4chst mit Wechselwirkungen h\u00e4ufig verwendeter Medikamente in der Kardiologie (AMB 2000, 34, 17), danach mit denen von Phytopharmaka (AMB 2000, 34, 43). Wir setzen diese Reihe fort mit klinisch wichtigen Wechselwirkungen antimikrobieller Substanzen. Antimikrobielle Medikamente (Antibiotika, Virostatika, Antimykotika, Tuberkulostatika) werden sehr h\u00e4ufig nicht [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Wir haben uns in diesem Jahr zweimal ausf\u00fchrlich mit bedeutsamen Arzneimittelinteraktionen besch\u00e4ftigt: zun\u00e4chst mit Wechselwirkungen h\u00e4ufig verwendeter Medikamente in der Kardiologie (AMB 2000, 34, 17), danach mit denen von Phytopharmaka (AMB 2000, 34, 43). Wir setzen diese Reihe fort mit klinisch wichtigen Wechselwirkungen antimikrobieller Substanzen. Antimikrobielle Medikamente (Antibiotika, Virostatika, Antimykotika, Tuberkulostatika) werden sehr h\u00e4ufig nicht [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1686,74,619,1687,22,616,290,343,1180,137,58,1694,1047,77,76,1683,584,1178,1690,1688,1691,587,294,345,1692,1693,178,1601,1602,289,329,1685,1684,1689,610,1695,1704,646,631,643,64,67,1699,1701,117,1697,1696,1698,1702,1703,296,679,138,765,1700,1681,1680,571,1679,1682,105,103,1678,341,52,136,1044,262,264],"class_list":["post-682","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-5-flucytosin","tag-acetylsalicylsaeure","tag-allopurinol","tag-aminoglykoside","tag-amoxicillin","tag-amphotericin-b","tag-ampicillin","tag-antibiotika","tag-antidiabetika","tag-antikoagulanzien","tag-antikonzeptiva","tag-antimikrobielle-substanzen","tag-arzneimittelinteraktionen","tag-ass","tag-azetylsalizylsaeure","tag-brivudin","tag-cefalosporine","tag-cefazolin","tag-cefotiam","tag-ceftazidim","tag-cefuroximaxetil","tag-cephalosporine","tag-ciprofloxacin","tag-clindamycin","tag-co-trimoxazol","tag-cotrimoxazol","tag-digoxin","tag-doxycyclin","tag-doxyzyklin","tag-erythromycin","tag-fluconazol","tag-fluorchinolone","tag-fluorochinolone","tag-foscarnet","tag-furosemid","tag-ganciclovir","tag-imipenem-cilastin","tag-inh","tag-isoniazid","tag-itraconazol","tag-kontrazeption","tag-kontrazeptiva","tag-levofloxacin","tag-makrolide","tag-metronidazol","tag-mezlocilln","tag-muskelrelaxanzien","tag-n-acetylcystein","tag-neomycin","tag-nephrotoxische-substanzen","tag-ofloxacin","tag-penicilline","tag-phenprocoumon","tag-phenytoin","tag-piperacillin","tag-pyrazinamid","tag-pyrimethamin","tag-rifampicin","tag-schleifendiuretika","tag-sulfonamide","tag-tetracycline","tag-tetrazykline","tag-trimethoprim-sulfamethoxazol","tag-vancomycin","tag-verhuetung","tag-warfarin","tag-wechselwirkungen","tag-zytostatika","tag-zytostatische-therapie"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/682","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=682"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/682\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=682"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=682"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=682"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}